Neurotrope to Present at the Ladenburg Thalmann 2018 Healthcare Conference

Thursday, September 27, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Sept. 27, 2018 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing

novel therapies for neurodegenerative diseases, including Alzheimer's disease, today announced that Dr. Charles Ryan, Neurotrope's Chief Executive Officer, will present a company overview at the Ladenburg Thalmann 2018
Healthcare Conference in New York on Tuesday, October 2nd, 2018 at 9:30 a.m. Eastern Time.

A live webcast of the presentation will be available on the "Events and Presentations" page in the "Investors and Media" section of the Company's website at http://www.neurotrope.com/. The presentation will be archived on the Company's website and be available for replay for 90 days.

Below is a direct link to the live webcast:

http://wsw.com/webcast/ladenburg4/ntrp/

About Neurotrope

Neurotrope is at the forefront of developing a new approach to combating AD and other neurodegenerative diseases. The Company's world-class science offers the potential to realize a paradigm shift to overcome one of today's most challenging clinical problems — finding a way to slow or even prevent the progression of AD.

In addition to the Company's Phase 2 trial of Bryostatin-1 in advanced AD, Neurotrope has also conducted preclinical studies of Bryostatin-1 as a potential treatment for Stroke, Traumatic Brain Injury, and Fragile X Syndrome, and Niemann-Pick Type C disease — rare genetic diseases for which only symptomatic treatments are currently available. The FDA has granted Orphan Drug Designation to Neurotrope for Bryostatin-1 as a treatment for Fragile X. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs.

Please visit www.neurotrope.com for further information.

Contact information:

Sam Martin / Ryan BakerArgot Partners212.600.1902neurotrope@argotpartners.com

Cision View original content:http://www.prnewswire.com/news-releases/neurotrope-to-present-at-the-ladenburg-thalmann-2018-healthcare-conference-300720075.html

SOURCE Neurotrope, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store